Production of pancreatic islet cells and delivery of insulin
CA 2441564 A1 · Owner: The Regents Of The University Of California · Inventors: German, Michael S.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to the production of islet cells and insulin in a subject by providing for expression of an islet transcription factors in the pancreas of the subject, by for example introduction of nucleic acid encoding an islet transcription factor or a factor that induces expression of an islet transcription factor, with Ngn3, NeuroD1 and Mash1 being of particular , interest. The present invention also relates to methods for using an islet transcription factor gene and the islet transcription factor polypeptide to alter cellular differentiation in culture orin vivo to produce new .beta.cells to treat patients with diabetes mellitus. The present invention will be …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed March 20, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended March 20, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 20, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.